These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32702599)

  • 21. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
    Cabrero-de Las Heras S; Martínez-Balibrea E
    World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and clinical prognostic value of CYB561 in breast cancer.
    Zhou X; Shen G; Ren D; Guo X; Han J; Guo Q; Zhao F; Wang M; Dong Q; Li Z; Zhao J
    J Cancer Res Clin Oncol; 2022 Aug; 148(8):1879-1892. PubMed ID: 35486183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the role of FADS family members in breast cancer based on bioinformatic analysis and experimental validation.
    Zhao T; Gao P; Li Y; Tian H; Ma D; Sun N; Chen C; Zhang Y; Qi X
    Front Immunol; 2023; 14():1074242. PubMed ID: 37122728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
    Bonneau C; Eliès A; Kieffer Y; Bourachot B; Ladoire S; Pelon F; Hequet D; Guinebretière JM; Blanchet C; Vincent-Salomon A; Rouzier R; Mechta-Grigoriou F
    Breast Cancer Res; 2020 Jul; 22(1):76. PubMed ID: 32665033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in Breast Cancer.
    Lin T; Qiu Y; Peng W; Peng L
    Biomed Res Int; 2020; 2020():2148253. PubMed ID: 33145341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction.
    Sun Y; Yang M; Zhang Q
    Ann Transl Med; 2022 Dec; 10(24):1379. PubMed ID: 36660642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization, structural and expression analysis of twelve CXC chemokines and eight CXC chemokine receptors in largemouth bass (Micropterus salmoides).
    Qi Z; Xu Y; Dong B; Pi X; Zhang Q; Wang D; Wang Z
    Dev Comp Immunol; 2023 Jun; 143():104673. PubMed ID: 36858298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer.
    Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
    Breast Cancer; 2020 Jul; 27(4):573-585. PubMed ID: 31960363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer.
    Park IH; Kong SY; Ro JY; Kwon Y; Kang JH; Mo HJ; Jung SY; Lee S; Lee KS; Kang HS; Lee E; Joo J; Ro J
    Clin Breast Cancer; 2016 Feb; 16(1):51-8. PubMed ID: 26364145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the prognostic values of CXCR family in gastric cancer.
    Yu C; Zhang Y
    Cytokine; 2019 Nov; 123():154785. PubMed ID: 31344595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive bioinformatics analysis to identify potential prognostic biomarkers among CC and CXC chemokines in breast cancer.
    Hozhabri H; Moghaddam MM; Moghaddam MM; Mohammadian A
    Sci Rep; 2022 Jun; 12(1):10374. PubMed ID: 35725915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive Analysis of the Expression, Prognosis, and Immune Infiltrates for Chromodomain-Helicase-DNA-Binding Proteins in Breast Tumor.
    Hasanlu M; Amiri-Dashatan N; Farahani M; Koushki M; Ahmadi H; Parsamanesh N; Ahmadi NA
    Asian Pac J Cancer Prev; 2024 May; 25(5):1547-1558. PubMed ID: 38809626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer.
    Zhong L; Yang Z; Lei D; Li L; Song S; Cao D; Liu Y
    Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):169-182. PubMed ID: 32799413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic characterization of the expression, prognosis and immune characteristics of PLOD family genes in breast cancer.
    Wang DD; Li L; Fu YQ; Yang SJ; Chen X; Hou JC; Zhang Q; Tian XX; Tang JH; Zhang J; Zhang HD
    Aging (Albany NY); 2024 Jul; 16(14):11434-11445. PubMed ID: 39068670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
    Wu W; Qian L; Chen X; Ding B
    Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic and immunological value of
    Wang J; Liu Y; Zhang S
    Aging (Albany NY); 2021 Jul; 13(13):16904-16921. PubMed ID: 34228637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the prognostic significance of solute carrier (SLC) family 39 genes in breast cancer.
    Liu L; Yang J; Wang C
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer.
    Yu L; Yang X; Xu C; Sun J; Fang Z; Pan H; Han W
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107077. PubMed ID: 33068862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival.
    Okano M; Oshi M; Butash AL; Asaoka M; Katsuta E; Peng X; Qi Q; Yan L; Takabe K
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation.
    Zhao W; Chang Y; Wu Z; Jiang X; Li Y; Xie R; Fu D; Sun C; Gao J
    PeerJ; 2023; 11():e15703. PubMed ID: 37483962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.